Logo wahanariau.com
  2. Jerman

Jerman

Index
Globenewswire

Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter

Senin, 20 April 2026 - 20:12:34 Wib
Globenewswire

Schneider Electric and Deloitte collaborate to drive AI-enabled digital transformation across industrial operations

Senin, 20 April 2026 - 20:06:29 Wib
Globenewswire

Challenge accepted: Schneider Electric helps industry turn toughest problems into competitive advantage

Ahad, 19 April 2026 - 22:47:40 Wib
Globenewswire

Schneider Electric unveils next generation agentic manufacturing capabilities powered by Microsoft Azure AI at Hannover Messe 2026

Kamis, 16 April 2026 - 22:30:56 Wib
Globenewswire

Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine

Kamis, 16 April 2026 - 21:35:03 Wib
Globenewswire

Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas

Rabu, 15 April 2026 - 21:52:00 Wib
Globenewswire

Nemetschek Group to Acquire HCSS; Creates Next Global Construction Technology Leader

Selasa, 14 April 2026 - 20:54:07 Wib
Globenewswire

Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer

Kamis, 09 April 2026 - 20:42:52 Wib
Globenewswire

GetYourGuide Launches Global Brand Campaign

Kamis, 26 Maret 2026 - 02:25:23 Wib
Globenewswire

PDI Technologies Helps EMEA Retailers Operate Smarter at UNITI expo 2026

Selasa, 24 Maret 2026 - 04:31:42 Wib
Globenewswire

Digitization Level of Industry: India Claims 3rd Place Behind the U.S. and China

Kamis, 19 Maret 2026 - 04:02:56 Wib
Globenewswire

China takes the lead in all Industry 4.0 technologies, ahead of U.S. and Europe

Kamis, 19 Maret 2026 - 03:59:51 Wib
Globenewswire

GetYourGuide Appoints Rob Rekrutiak as Chief Product Officer

Selasa, 03 Maret 2026 - 05:05:18 Wib
Globenewswire

RIB Unite 2026: Connecting Construction Together

Selasa, 03 Maret 2026 - 04:56:30 Wib
Globenewswire

FDA approves HERNEXEOS®, the first targeted therapy for adults with HER2-mutant advanced NSCLC as an initial treatment option

Jumat, 27 Februari 2026 - 20:06:33 Wib
Globenewswire

Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics

Kamis, 26 Februari 2026 - 21:56:02 Wib
Globenewswire

Deutsche Telekom Melaporkan Penghematan Energi hingga 65% pada Jaringan Inti 5G, yang Dikembangkan dengan Dukungan Mavenir

Kamis, 26 Februari 2026 - 21:48:20 Wib
Globenewswire

Deutsche Telekom Reports up to 65% Energy Savings in 5G Core Network, Developed With Support From Mavenir

Rabu, 25 Februari 2026 - 21:21:42 Wib
Globenewswire

Embedded LLM Launches the EU AI Grid at Munich Cyber Security Conference (MCSC) to Meet EU Demand for Sovereign AI Capability

Senin, 16 Februari 2026 - 06:21:26 Wib
Globenewswire

Boehringer Ingelheim and Simcere partner to advance a dual-target antibody treatment to address unmet needs in inflammatory bowel disease

Selasa, 27 Januari 2026 - 22:02:20 Wib
Globenewswire

Boehringer Ingelheim advances potential first-in-class IL-11 inhibitor to Phase II Clinical Research in Idiopathic Pulmonary Fibrosis

Rabu, 14 Januari 2026 - 05:17:38 Wib
Globenewswire

Boehringer Ingelheim announces clinical collaboration with Jazz Pharmaceuticals to advance HER2-targeted therapy in breast cancer

Selasa, 13 Januari 2026 - 06:03:08 Wib
Globenewswire

SearchneedsLOVE Disrupts Digital Advertising Market with Global Launch of Accountability-Driven SEO Platform

Jumat, 09 Januari 2026 - 06:11:34 Wib
Globenewswire

Miltenyi Biomedicine Memaparkan Analisis Primer dari Uji Klinis DALY 2-EU yang Penting untuk Limfoma Sel B Besar yang Kambuh/refraktori Pada Lini Kedua pada Pertemuan Tahunan American Society of Haematology (ASH) ke-67

Senin, 08 Desember 2025 - 22:00:03 Wib
Globenewswire

Miltenyi Biomedicine Presents Primary Analysis of the Pivotal DALY 2-EU Trial for Second-line Relapsed/refractory Large B-cell Lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Senin, 08 Desember 2025 - 21:52:23 Wib